Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox

The requirements of a specialist breast centre

(2020) Laura Biganzoli et al.   BREAST

Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

(2020) Mehra Golshan et al.   JAMA Surgery

Role of MRI to Assess Response to Neoadjuvant Therapy for Breast Cancer

(2020) Beatriu Reig et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy

(2020) Giacomo Montagna et al.   ANNALS OF SURGICAL ONCOLOGY

The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial

(2020) Peter C. Dubsky et al.   EUROPEAN JOURNAL OF CANCER

Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer–Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial

(2020) George E. Naoum et al.   JOURNAL OF CLINICAL ONCOLOGY

Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index

(2019) Laura L. Michel et al.   PLoS One

Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration

(2019) Samuel C.Y. Leung et al.   HISTOPATHOLOGY

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2019) F Cardoso et al.   ANNALS OF ONCOLOGY

Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

(2019) H J Burstein et al.   ANNALS OF ONCOLOGY

Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools

(2019) Maria Adele Marino et al.   ONCOLOGIST

Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure

(2018) M. E. M. van der Noordaa et al.   ANNALS OF SURGICAL ONCOLOGY

Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?

(2018) Tracy-Ann Moo et al.   ANNALS OF SURGICAL ONCOLOGY

Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis

(2018) Antonios Valachis et al.   CANCER

Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis

(2018) Carmen Criscitiello et al.   EUROPEAN JOURNAL OF CANCER

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

(2018) Bernard Asselain et al.   LANCET ONCOLOGY

Margins in Breast-Conserving Surgery After Neoadjuvant Therapy

(2018) Jungeun Choi et al.   ANNALS OF SURGICAL ONCOLOGY

Patient-Reported Outcome Measures May Add Value in Breast Cancer Surgery

(2018) M. Lagendijk et al.   ANNALS OF SURGICAL ONCOLOGY

Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study

(2018) Balazs Acs et al.   LABORATORY INVESTIGATION

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

(2018) Jean-Marc Classe et al.   BREAST CANCER RESEARCH AND TREATMENT

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

(2018) Gunter von Minckwitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

(2017) Norikazu Masuda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Axillary Nodal Management Following Neoadjuvant Chemotherapy

(2017) Melissa Pilewskie et al.   JAMA Oncology

Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy

(2016) Judy C. Boughey et al.   ANNALS OF SURGERY

Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer

(2016) Jose Vila et al.   ANNALS OF SURGICAL ONCOLOGY

How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

(2016) Anita Mamtani et al.   ANNALS OF SURGICAL ONCOLOGY

Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes

(2016) Emilia J. Diego et al.   ANNALS OF SURGICAL ONCOLOGY

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)

(2016) Mehra Golshan et al.   BREAST CANCER RESEARCH AND TREATMENT

The breast cancer conservative treatment. Cosmetic results – BCCT.core – Software for objective assessment of esthetic outcome in breast cancer conservative treatment: A narrative review

(2016) Maria João Cardoso et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

RECIST 1.1—Update and clarification: From the RECIST committee

(2016) Lawrence H. Schwartz et al.   EUROPEAN JOURNAL OF CANCER

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

(2016) Abigail S. Caudle et al.   JOURNAL OF CLINICAL ONCOLOGY

Detectability of Hygroscopic Clips Used in Breast Cancer Surgery

(2016) Moshe Carmon et al.   JOURNAL OF ULTRASOUND IN MEDICINE

The Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Initially Clinically Node-Negative Breast Cancer after Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis

(2016) Chong Geng et al.   PLoS One

Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy

(2016) Sarah S. Mougalian et al.   JAMA Oncology

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

(2015) V. Bossuyt et al.   ANNALS OF ONCOLOGY

Factors Affecting Sentinel Lymph Node Identification Rate After Neoadjuvant Chemotherapy for Breast Cancer Patients Enrolled in ACOSOG Z1071 (Alliance)

(2015) Judy C. Boughey et al.   ANNALS OF SURGERY

Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference

(2015) Jeffrey Landercasper et al.   ANNALS OF SURGICAL ONCOLOGY

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

(2015) Jean-Francois Boileau et al.   JOURNAL OF CLINICAL ONCOLOGY

Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy

(2015) Tari A. King et al.   Nature Reviews Clinical Oncology

Regional Nodal Irradiation in Early-Stage Breast Cancer

(2015) Timothy J. Whelan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Selective Surgical Localization of Axillary Lymph Nodes Containing Metastases in Patients With Breast Cancer

(2015) Abigail S. Caudle et al.   JAMA Surgery

Impact of Multifocal or Multicentric Disease on Surgery and Locoregional, Distant and Overall Survival of 6,134 Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

(2014) Beyhan Ataseven et al.   ANNALS OF SURGICAL ONCOLOGY

Assessing cosmetic results after breast conserving surgery

(2014) Maria João Cardoso et al.   JOURNAL OF SURGICAL ONCOLOGY

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

(2014) Patricia Cortazar et al.   LANCET

Is axillary lymph node clearance required in node-positive breast cancer?

(2014) Nigel J. Bundred et al.   Nature Reviews Clinical Oncology

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

(2013) A. Schneeweiss et al.   ANNALS OF ONCOLOGY

Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy

(2013) Stefan Glück et al.   BREAST CANCER RESEARCH AND TREATMENT

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer

(2013) Judy C. Boughey   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Locoregional Radiotherapy in Patients With Breast Cancer Responding to Neoadjuvant Chemotherapy: A Paradigm for Treatment Individualization

(2013) Julia White et al.   JOURNAL OF CLINICAL ONCOLOGY

Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial

(2013) André Robidoux et al.   LANCET ONCOLOGY

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

(2013) Thorsten Kuehn et al.   LANCET ONCOLOGY

Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27

(2012) Eleftherios P. Mamounas et al.   JOURNAL OF CLINICAL ONCOLOGY

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

(2012) José Baselga et al.   LANCET

The BREAST-Q

(2012) Stefan J. Cano et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women

(2012) E. M. Kesson et al.   BMJ-British Medical Journal

Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy

(2011) Catherine L. Akay et al.   ANNALS OF SURGICAL ONCOLOGY

A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer

(2011) Christos Hatzis   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups

(2011) Michael Untch et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

(2011) Luca Gianni et al.   LANCET ONCOLOGY

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

(2010) M. E. Straver et al.   ANNALS OF SURGICAL ONCOLOGY

Breast MRI: guidelines from the European Society of Breast Imaging

(2008) R. M. Mann et al.   EUROPEAN RADIOLOGY